Top Cancer Stocks 2015 - Right now, the Top Cancer
Stock in 2015 is Agios Pharmaceuticals (AGIO). Agios Pharmaceuticals (AGIO) is up 80% in the last three months
and up 380% in the past year heading into 2015. The company is developing a cancer drug to treat Advanced Acute Myeloid
Leukemia, or cancer of the blood. In a phase 1 trial, 7 out of 14 people responded to the drug with 4 patients
having complete remission. So far, this cancer drug seems to be working but we will receive more data in 2015.
Watch AGIO in 2015 because if their cancer drug data improves, we could be looking at a $150-$180 stock.
Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the
field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. Its product candidates include AG-221,
an oral inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein for the treatment of patients with cancers that
harbor IDH2 mutations, as well as for the Type II D-2 hydroxyglutaric aciduria treatment; and AG-120, an oral inhibitor of
the mutated IDH1 protein for the treatment of patients with cancers that harbor IDH1 mutations.